Literature DB >> 12507905

CCN5 is a growth arrest-specific gene that regulates smooth muscle cell proliferation and motility.

Andrew C Lake1, Ann Bialik, Kenneth Walsh, John J Castellot.   

Abstract

Vascular smooth muscle cell (VSMC) hyperplasia plays an important role in both chronic and acute vascular pathologies. Considerable work has focused on the mechanisms regulating VSMC growth and the search for agents that could suppress VSMC hyperproliferation. One of the several inhibitors studied is the glycosaminoglycan heparin, which inhibits VSMC proliferation and migration both in cell culture and in animal models (Mishra-Gorur K, Delmolino LM, Castellot Jr JJ: Biological functions of heparan sulfate and heparan sulfate proteoglycans. Trends Glycosci Glycotechnol 1998, 10:193-210). To aid our understanding of the anti-proliferative mechanism of action of heparin, we used a subtractive hybridization approach to isolate and characterize a novel growth arrest-specific (gas) gene induced in VSMCs exposed to heparin (Delmolino LM, Stearns NA, Castellot Jr JJ: Heparin induces a member of the CCN family which has characteristics of a growth arrest specific gene. Mol Biol Cell 1997, 8:287a and Delmolino LM, Stearns NA, Castellot Jr JJ: COP-1, a member of the CCN family, is a heparin-induced growth arrest specific gene in vascular smooth muscle cells. J Cell Physiol 2001, 188:45-55). This gene is a member of the cysteine-rich 61/connective tissue growth factor/nephroblastoma-overexpressed (CCN) family and has been given the name CCN5. In this report, we provide functional evidence that CCN5 can inhibit VSMC proliferation, motility, and invasiveness. In contrast, adhesion and apoptosis are unaffected by CCN5 in this cell type. We also significantly extend previous data from our laboratory that suggests CCN5 is a growth arrest-specific (gas) gene. Furthermore, we map for the first time the cellular localization of CCN5 protein in cultured VSMCs. We also examine uninjured and balloon-injured rat carotid arteries for CCN5 expression. The results from the in vitro and in vivo localization studies show that CCN5 is temporally and spatially expressed in a manner consistent with a role in regulating proliferation, motility, and invasiveness of VSMCs.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12507905      PMCID: PMC1851113          DOI: 10.1016/S0002-9440(10)63813-8

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  39 in total

1.  Report and abstracts on the first international workshop on the CCN family of genes.

Authors:  C Ayer-Lelievre; D Brigstock; L Lau; D Pennica; B Perbal; H Yeger
Journal:  Mol Pathol       Date:  2001-04

2.  Nov gene encodes adhesion factor for vascular smooth muscle cells and is dynamically regulated in response to vascular injury.

Authors:  P D Ellis; Q Chen; P J Barker; J C Metcalfe; P R Kemp
Journal:  Arterioscler Thromb Vasc Biol       Date:  2000-08       Impact factor: 8.311

3.  Overexpression of the V3 variant of versican alters arterial smooth muscle cell adhesion, migration, and proliferation in vitro.

Authors:  Joan M Lemire; Mervyn J Merrilees; Kathleen R Braun; Thomas N Wight
Journal:  J Cell Physiol       Date:  2002-01       Impact factor: 6.384

4.  WISP-2: a serum-inducible gene differentially expressed in human normal breast epithelial cells and in MCF-7 breast tumor cells.

Authors:  M N Zoubine; S Banerjee; N K Saxena; D R Campbell; S K Banerjee
Journal:  Biochem Biophys Res Commun       Date:  2001-03-30       Impact factor: 3.575

5.  Overexpression of connective tissue growth factor gene induces apoptosis in human aortic smooth muscle cells.

Authors:  K Hishikawa; B S Oemar; F C Tanner; T Nakaki; T Fujii; T F Lüscher
Journal:  Circulation       Date:  1999-11-16       Impact factor: 29.690

6.  Shear stress downregulation of platelet-derived growth factor receptor-beta and matrix metalloprotease-2 is associated with inhibition of smooth muscle cell invasion and migration.

Authors:  R Palumbo; C Gaetano; G Melillo; E Toschi; A Remuzzi; M C Capogrossi
Journal:  Circulation       Date:  2000-07-11       Impact factor: 29.690

7.  COP-1, a member of the CCN family, is a heparin-induced growth arrest specific gene in vascular smooth muscle cells.

Authors:  L M Delmolino; N A Stearns; J J Castellot
Journal:  J Cell Physiol       Date:  2001-07       Impact factor: 6.384

8.  WISP-2 as a novel estrogen-responsive gene in human breast cancer cells.

Authors:  H Inadera; S Hashimoto; H Y Dong; T Suzuki; S Nagai; T Yamashita; N Toyoda; K Matsushima
Journal:  Biochem Biophys Res Commun       Date:  2000-08-18       Impact factor: 3.575

9.  Connective tissue growth factor induces apoptosis in human breast cancer cell line MCF-7.

Authors:  K Hishikawa; B S Oemar; F C Tanner; T Nakaki; T F Lüscher; T Fujii
Journal:  J Biol Chem       Date:  1999-12-24       Impact factor: 5.157

10.  The chemotactic attraction of human fibroblasts to a lymphocyte-derived factor.

Authors:  A E Postlethwaite; R Snyderman; A H Kang
Journal:  J Exp Med       Date:  1976-11-02       Impact factor: 14.307

View more
  36 in total

Review 1.  Taking aim at the extracellular matrix: CCN proteins as emerging therapeutic targets.

Authors:  Joon-Il Jun; Lester F Lau
Journal:  Nat Rev Drug Discov       Date:  2011-12-01       Impact factor: 84.694

Review 2.  The CCN proteins: important signaling mediators in stem cell differentiation and tumorigenesis.

Authors:  Guo-Wei Zuo; Christopher D Kohls; Bai-Cheng He; Liang Chen; Wenli Zhang; Qiong Shi; Bing-Qiang Zhang; Quan Kang; Jinyong Luo; Xiaoji Luo; Eric R Wagner; Stephanie H Kim; Farbod Restegar; Rex C Haydon; Zhong-Liang Deng; Hue H Luu; Tong-Chuan He; Qing Luo
Journal:  Histol Histopathol       Date:  2010-06       Impact factor: 2.303

3.  CCN5, a secreted protein, localizes to the nucleus.

Authors:  Kristina C Wiesman; Lan Wei; Cassandra Baughman; Joshua Russo; Mark R Gray; John J Castellot
Journal:  J Cell Commun Signal       Date:  2010-03-18       Impact factor: 5.782

4.  CCN5: biology and pathophysiology.

Authors:  Joshua W Russo; John J Castellot
Journal:  J Cell Commun Signal       Date:  2010-09-21       Impact factor: 5.782

Review 5.  Matricellular proteins in cardiac adaptation and disease.

Authors:  Nikolaos G Frangogiannis
Journal:  Physiol Rev       Date:  2012-04       Impact factor: 37.312

Review 6.  Genomic profiling of mesenchymal stem cells.

Authors:  Danijela Menicanin; P Mark Bartold; Andrew C W Zannettino; Stan Gronthos
Journal:  Stem Cell Rev Rep       Date:  2009-02-18       Impact factor: 5.739

7.  CCN5 Expression in mammals. II. Adult rodent tissues.

Authors:  Mark R Gray; Jennifer A Malmquist; Matthew Sullivan; Michael Blea; John J Castellot
Journal:  J Cell Commun Signal       Date:  2007-11-13       Impact factor: 5.782

8.  Spatial-temporal modulation of CCN proteins during wound healing in human skin in vivo.

Authors:  Laure Rittié; Bernard Perbal; John J Castellot; Jeffrey S Orringer; John J Voorhees; Gary J Fisher
Journal:  J Cell Commun Signal       Date:  2011-01-11       Impact factor: 5.782

9.  Emerging roles of CCN proteins in vascular development and pathology.

Authors:  Philip A Klenotic; Chao Zhang; Zhiyong Lin
Journal:  J Cell Commun Signal       Date:  2016-05-30       Impact factor: 5.782

10.  Domain-and species-specific monoclonal antibodies recognize the Von Willebrand Factor-C domain of CCN5.

Authors:  Lan Wei; Frank McKeon; Joshua W Russo; Joan Lemire; John Castellot
Journal:  J Cell Commun Signal       Date:  2009-04-29       Impact factor: 5.782

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.